[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

@Longroaderstar Avatar @Longroaderstar Longroader

Longroader posts on X about $vtyx, $wve, $arwr, $mreo the most. They currently have XXX followers and XX posts still getting attention that total XXX engagements in the last XX hours.

Engagements: XXX #

Engagements Line Chart

Mentions: XX #

Mentions Line Chart

Followers: XXX #

Followers Line Chart

CreatorRank: XXXXXXXXX #

CreatorRank Line Chart

Social Influence

Social category influence stocks XX% finance XXXX% cryptocurrencies XXXX%

Social topic influence $vtyx #5, $wve #39, $arwr #23, $mreo #10, target 8.33%, sanofi 8.33%, $rna 8.33%, $sgmo 8.33%, $mgx #10, stocks XXXX%

Top accounts mentioned or mentioned by @andersresearch @bioboyscout @naturemedicine @biotechiq @rnaianalyst @anders_research @duikb00t

Top assets mentioned Wave Life Sciences Ltd. Ordinary Shares (WVE) Arrowhead Research Corporation (ARWR) Sanofi (SNY) Avidity Biosciences, Inc. Common Stock (RNA) GSK plc (GSK) Novartis AG (NVS) Ionis Pharmaceuticals, Inc. Common Stock (IONS) Alnylam Pharmaceuticals, Inc. (ALNY) Intellia Therapeutics, Inc (NTLA) BEAM (BEAM) CRISPR Therapeutics AG (CRSP) Sarepta Therapeutics, Inc. (SRPT)

Top Social Posts

Top posts by engagements in the last XX hours

"$mreo Doubled my small stake hovering around $X and upside is significant with huge unmet need. CMO gave off good vibes at Citi recently"
X Link 2025-12-06T01:55Z XXX followers, XXX engagements

"$wve $arwr Hold on to your stocks 🚀 Once or twice yearly dosing Lean mass preserved Similar fat loss as GLP1 Safe Wave is now a very attractive buyout target. $GSK"
X Link 2025-12-08T13:56Z XXX followers, XXX engagements

"$vtyx At $XX Ventyx is now $707m mcap and $500m EV. For VTX3232 a move by Sanofi for Parkinson's should be around this valuation similar to Vigil"
X Link 2025-11-25T14:42Z XXX followers, XXX engagements

"$VTYX For cardiometabolic Tourmaline was acquired for $1.4b by Novartis. Recent acquisition of $RNA shows multiple acquirers interested. Sanofi may have the ROFN process but that does not stop unsolicited offers"
X Link 2025-11-25T14:46Z XXX followers, XXX engagements

"@Anders_Research My point is once you have one BP interested the rest sits up and the bids get interesting. Esp with pressure to acquire. $vtyx $rna"
X Link 2025-11-25T15:15Z XXX followers, XXX engagements

"$sgmo Building back confidence one brick at a time"
X Link 2025-12-02T13:24Z XXX followers, XXX engagements

"$ARWR Arrow at $XXX is same market cap as Ionis. Market discovery of this 'gap' is on-going"
X Link 2025-12-04T00:29Z XXX followers, 1397 engagements

"$ARWR PDUFA today. Hope to get a broad label approval. This will be one for the RNAi history books and sweet success for investors and patients. 🙏 10x to $ALNY next"
X Link 2025-11-18T08:58Z XXX followers, 2975 engagements

"$sgmo $ntla $beam $edit $prme $mgx $crsp $srpt There will a market for gene editing and patients want it"
X Link 2025-11-24T15:40Z XXX followers, 1990 engagements

"$MGX Cardiometabolic target revealed for IONIS. APOC3"
X Link 2025-12-01T14:29Z XXX followers, XXX engagements

"$VTYX The X new advisors are huge step forward for Ventyx: Mark McKenna will provide great strategic advice in M&A. Peter Libby is world renowned expert in cardiovascular diseases. He also sits on the SAB of Amgen and Esperion both with cardio interest"
X Link 2025-12-02T13:44Z XXX followers, 1852 engagements

"$mreo Data readout coming very soon maybe days. If it hits expect a Capricor-like effect on stock price. Shorts are warned"
X Link 2025-12-03T15:18Z XXX followers, XXX engagements

"@_Biotech_iQ $vtyx Great table. XXX can indeed go head to head with XXX. If they can secure a partner and bring this forward the valuation gap is huge. CEO did hint they also have 'other assets' to bring forward in Piper sharing. And 3232 should decided in about a month. #jpm26"
X Link 2025-12-08T02:32Z XXX followers, XXX engagements

"$wve $arwr Next-gen obesity RNAi targeting INHBE huge readout today for Wave and in Jan XX for Arrowhead. Expectations of GLP1-like fast weight loss is low main focus is on muscle loss and others"
X Link 2025-12-08T09:42Z XXX followers, 1320 engagements

"@RNAiAnalyst $wve They should. Like Cidara. Raising cash will strengthen their hand if any BP pursues them. $10b Metsera"
X Link 2025-12-08T16:42Z XXX followers, XXX engagements

"$WVE Pricing $XX $350m. Strong demand"
X Link 2025-12-10T07:23Z XXX followers, XXX engagements